Role of GRAIL in CD25+ T Regulatory Cells

GRAIL 在 CD25 T 调节细胞中的作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): The recent characterization of CD25+ T regulatory (CD25 Treg) cells has underscored the importance of these cells in modulating immune responses in a broad range of disease states. CD25 Treg cells are a subset of regulatory T cells with an anergic phenotype that suppress immune responses in an antigen specific fashion by a poorly understood mechanism. To date, the only unique genetic marker in CD25 Treg cells is the transcription factor, Foxp3. Studies from our laboratory have demonstrated a link between GRAIL, an E3 ubiquitin ligase that is necessary for the development of CD4 T cell anergy in vivo, and CD25 Treg cells. We hypothesize that GRAIL is important for the development and function of naturally occurring and induced CD25 Treg cells. Several lines of evidence support this hypothesis: 1) GRAIL is expressed in naturally occurring CD25 Treg cells at levels 10-fold greater than CD25- CD4 T cells, 2) a tolerizing immunization in vivo leads to the induction of long-lived CD25 expressing antigen-specific tolerized T cells. Gene expression analysis of these cells reveals that GRAIL mRNA is upregulated (700-fold increase vs. CD25- tolerized; 100-fold increase vs, naturally occurring CD25 Treg cells). Moreover, GRAIL expression is linked with Foxp3 expression strongly suggesting a suppressor phenotype in this induced tolerized population. As an initial step to understanding the role of GRAIL in CD25 Treg cell suppressor function, we demonstrate that enforced expression of GRAIL in an antigen-specific T cell line is sufficient to convey a suppressor phenotype in vitro. The specific aims of this research proposal are: 1) To establish the role of GRAIL in naturally occurring CD25 Treg cell development and function by generating bone marrow chimeric mice expressing GRAIL, a dominant negative form, or GRAIL RNAi construct 2) To determine if GRAIL is upregulated in activated suppressor cells by functionally characterizing the induced CD25+ GRAIL expressing tolerized cells and establishing the kinetics of GRAIL expression in activated suppressor cells.
描述(由申请人提供):最近CD25+ T调节(CD25 Treg)细胞的特性强调了这些细胞在多种疾病状态下调节免疫反应的重要性。CD25 Treg细胞是调节性T细胞的一个亚群,具有无能表型,通过一种鲜为人知的机制以抗原特异性的方式抑制免疫反应。迄今为止,CD25 Treg细胞中唯一独特的遗传标记是转录因子Foxp3。我们实验室的研究已经证明了GRAIL和CD25 Treg细胞之间的联系,GRAIL是一种E3泛素连接酶,是体内CD4 T细胞能量发展所必需的。我们假设GRAIL对自然发生和诱导的CD25 Treg细胞的发育和功能很重要。有几条证据支持这一假设:1)GRAIL在自然发生的CD25 Treg细胞中的表达水平比CD25- CD4 T细胞高10倍;2)体内耐受免疫可诱导长寿命表达抗原特异性CD25的耐受T细胞。这些细胞的基因表达分析显示GRAIL mRNA上调(与CD25耐受细胞相比增加700倍;与自然发生的CD25 Treg细胞相比增加100倍)。此外,GRAIL的表达与Foxp3的表达密切相关,这表明在这种诱导耐受人群中存在抑制表型。作为了解GRAIL在CD25 Treg细胞抑制功能中的作用的第一步,我们证明了在抗原特异性T细胞系中强制表达GRAIL足以在体外传递抑制表型。本研究计划的具体目的是:1)通过生成表达GRAIL(显性阴性形式)或GRAIL RNAi构建体的骨髓嵌合小鼠,确定GRAIL在自然发生的CD25 Treg细胞发育和功能中的作用;2)通过功能表征诱导表达耐受细胞的CD25+ GRAIL,并建立激活抑制细胞中GRAIL的表达动力学,确定GRAIL是否在活化抑制细胞中上调。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHRISTINE Marie SEROOGY其他文献

CHRISTINE Marie SEROOGY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHRISTINE Marie SEROOGY', 18)}}的其他基金

Project 1: Immune development and respiratory outcomes in children from diverse Wisconsin communities
项目 1:来自威斯康星州不同社区的儿童的免疫发育和呼吸系统结果
  • 批准号:
    10634246
  • 财政年份:
    2013
  • 资助金额:
    $ 18.19万
  • 项目类别:
Role of GRAIL in CD25+ T Regulatory Cells
GRAIL 在 CD25 T 调节细胞中的作用
  • 批准号:
    7047944
  • 财政年份:
    2005
  • 资助金额:
    $ 18.19万
  • 项目类别:
GENE THERAPY IN ANIMAL MODEL OF AUTOIMMUNE DISEASE
自身免疫性疾病动物模型中的基因治疗
  • 批准号:
    6038130
  • 财政年份:
    2000
  • 资助金额:
    $ 18.19万
  • 项目类别:
GENE THERAPY IN ANIMAL MODEL OF AUTOIMMUNE DISEASE
自身免疫性疾病动物模型中的基因治疗
  • 批准号:
    6510050
  • 财政年份:
    2000
  • 资助金额:
    $ 18.19万
  • 项目类别:
GENE THERAPY IN ANIMAL MODEL OF AUTOIMMUNE DISEASE
自身免疫性疾病动物模型中的基因治疗
  • 批准号:
    6372684
  • 财政年份:
    2000
  • 资助金额:
    $ 18.19万
  • 项目类别:

相似海外基金

Impact of physical exercise on brain-bone marrow interactions in postmenopausal rats: potential mechanisms preventing menopause-induced hypertension
体育锻炼对绝经后大鼠脑-骨髓相互作用的影响:预防绝经期高血压的潜在机制
  • 批准号:
    24K20609
  • 财政年份:
    2024
  • 资助金额:
    $ 18.19万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Engineering the bone marrow niche to control stem cell regulation, metastatic evolution and cancer dormancy
改造骨髓生态位来控制干细胞调节、转移进化和癌症休眠
  • 批准号:
    EP/X036049/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.19万
  • 项目类别:
    Research Grant
Understanding the link between bone marrow failure and chronic inflammation through the lens of VEXAS syndrome
从 VEXAS 综合征的角度了解骨髓衰竭与慢性炎症之间的联系
  • 批准号:
    MR/Y011945/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.19万
  • 项目类别:
    Research Grant
Bone Marrow Adipogenesis in Response to Chemotherapy and Resultant Effect on Bone Metastasis
骨髓脂肪生成对化疗的反应及其对骨转移的影响
  • 批准号:
    491636
  • 财政年份:
    2023
  • 资助金额:
    $ 18.19万
  • 项目类别:
    Miscellaneous Programs
REGULATION OF BONE MARROW MESENCHYMAL STEM CELLS BY VCAM1
VCAM1 对骨髓间充质干细胞的调节
  • 批准号:
    10537391
  • 财政年份:
    2023
  • 资助金额:
    $ 18.19万
  • 项目类别:
Mechanisms of Parp inhibitor-induced bone marrow toxicities
Parp 抑制剂诱导骨髓毒性的机制
  • 批准号:
    10637962
  • 财政年份:
    2023
  • 资助金额:
    $ 18.19万
  • 项目类别:
Chromatin State Alterations in Fanconi Anemia Hematologic Disease and Bone Marrow Failure
范可尼贫血血液疾病和骨髓衰竭中的染色质状态改变
  • 批准号:
    10735366
  • 财政年份:
    2023
  • 资助金额:
    $ 18.19万
  • 项目类别:
Preserving bone marrow niche integrity and function to rejuvenate aged hematopoietic stem cells
保护骨髓生态位的完整性和功能,使老化的造血干细胞恢复活力
  • 批准号:
    10735925
  • 财政年份:
    2023
  • 资助金额:
    $ 18.19万
  • 项目类别:
Deep-UV Microscopy for Real-Time Adequacy Analysis of Bone Marrow Aspirates
用于骨髓抽吸物实时充分性分析的深紫外显微镜
  • 批准号:
    10761397
  • 财政年份:
    2023
  • 资助金额:
    $ 18.19万
  • 项目类别:
Selective Radionuclide Delivery for Precise Bone Marrow Niche Alterations
选择性放射性核素输送以实现精确的骨髓生态位改变
  • 批准号:
    10727237
  • 财政年份:
    2023
  • 资助金额:
    $ 18.19万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了